KNOW LABS Files Routine 8-K for Regulation FD and Exhibits
Ticker: USBC · Form: 8-K · Filed: Feb 27, 2024 · CIK: 1074828
| Field | Detail |
|---|---|
| Company | Know Labs, Inc. (USBC) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 K |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K filing, regulatory filing, corporate disclosure
TL;DR
**KNOW LABS filed a standard 8-K on Feb 27, but the actual news content isn't in this snippet.**
AI Summary
KNOW LABS, INC. filed a Form 8-K on February 27, 2024, reporting Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates the company's business address as 500 Union Street, Suite 810, Seattle, Washington 98101, and its state of incorporation as Nevada. The specific details of the disclosures, such as dollar amounts or names of individuals involved, are not provided in the given text.
Why It Matters
This 8-K filing serves as a public record of a regulatory event, ensuring transparency, but without the specific content of the disclosures, its real-world impact on investors or operations cannot be determined.
Risk Assessment
Risk Level: medium — The provided text is metadata for an 8-K filing and does not contain the actual content of the disclosures, preventing an assessment of specific risks or opportunities.
Key Players & Entities
- KNOW LABS, INC. (company) — registrant
- Nevada (company) — state of incorporation
- Seattle (company) — business address city
- Washington (company) — business address state
- February 27, 2024 (date) — date of report
FAQ
What type of SEC filing is this document?
This document is a Form 8-K, a current report filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the name of the registrant company?
The exact name of the registrant company as specified in its charter is KNOW LABS, INC.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is February 27, 2024.
What specific items of information are mentioned as being disclosed in this 8-K?
The 8-K mentions 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' under ITEM INFORMATION.
What is the business address of KNOW LABS, INC.?
The business address of KNOW LABS, INC. is 500 Union Street, Suite 810, Seattle, Washington 98101.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-02-27 09:03:51
Key Financial Figures
- $0.001 K — ch registered Common Stock, par value $0.001 KNW NYSE American LLC Indicate by chec
Filing Documents
- knwn_8k.htm (8-K) — 25KB
- knwn_ex991.htm (EX-99.1) — 13KB
- knwn_ex991img2.jpg (GRAPHIC) — 5KB
- 0001654954-24-002222.txt ( ) — 170KB
- knwn-20240227.xsd (EX-101.SCH) — 6KB
- knwn-20240227_lab.xml (EX-101.LAB) — 14KB
- knwn-20240227_cal.xml (EX-101.CAL) — 1KB
- knwn-20240227_pre.xml (EX-101.PRE) — 9KB
- knwn-20240227_def.xml (EX-101.DEF) — 2KB
- knwn_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On February 27, 2024, Know Labs, Inc. (the "Company") issued a press release announcing the KnowU, its wearable non-invasive continuous glucose monitor (CGM). The KnowU device will support accelerated data collection, including determining the technology's performance throughout continuous wear, on different locations on the body, and within more expansive glycemic ranges and diverse populations. The information included in this Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated February 27, 2024. Filed herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 27, 2024 KNOW LABS, INC. /s/ Ronald P. Erickson Name: Ronald P. Erickson Title: Chief Executive Officer 3